-
公开(公告)号:US20230346715A1
公开(公告)日:2023-11-02
申请号:US18217105
申请日:2023-06-30
申请人: NEXZOL PHARMA, INC.
IPC分类号: A61K31/05 , A61K47/18 , A61K47/58 , A61K47/36 , A61K9/50 , A61K9/06 , A61P37/02 , A61K9/127 , A61K9/00
CPC分类号: A61K31/05 , A61K47/183 , A61K47/58 , A61K47/36 , A61K9/5005 , A61K9/06 , A61P37/02 , A61K9/127 , A61K9/0014
摘要: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.
-
公开(公告)号:US11116730B2
公开(公告)日:2021-09-14
申请号:US16818755
申请日:2020-03-13
申请人: NEXZOL PHARMA, INC.
IPC分类号: A61K31/05 , A61K47/18 , A61K47/58 , A61K47/36 , A61K9/50 , A61K9/06 , A61P37/02 , A61K9/127 , A61K9/00
摘要: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.
-
公开(公告)号:US20210401770A1
公开(公告)日:2021-12-30
申请号:US17470788
申请日:2021-09-09
申请人: NEXZOL PHARMA, INC.
IPC分类号: A61K31/05 , A61K47/18 , A61K47/58 , A61K47/36 , A61K9/50 , A61K9/06 , A61P37/02 , A61K9/127 , A61K9/00
摘要: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.
-
公开(公告)号:US11723880B2
公开(公告)日:2023-08-15
申请号:US17470788
申请日:2021-09-09
申请人: NEXZOL PHARMA, INC.
IPC分类号: A61K31/05 , A61K9/00 , A61K9/06 , A61K9/127 , A61K9/50 , A61K47/18 , A61K47/58 , A61K47/36 , A61P37/02
CPC分类号: A61K31/05 , A61K9/0014 , A61K9/06 , A61K9/127 , A61K9/5005 , A61K47/183 , A61K47/36 , A61K47/58 , A61P37/02
摘要: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.
-
公开(公告)号:US10588871B1
公开(公告)日:2020-03-17
申请号:US16457746
申请日:2019-06-28
申请人: NEXZOL PHARMA, INC.
IPC分类号: A61K9/70 , A61K9/107 , A61K9/00 , A61K31/05 , A61K36/185 , A61K47/18 , A61K47/58 , A61K47/36 , A61K9/50 , A61K9/06 , A61P37/02 , A61K9/127
摘要: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.
-
-
-
-